Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer

Locally advanced non-small cell lung cancer (NSCLC) is a heterogeneous disease, and we have embarked on an era where patients will benefit from individualized therapeutic strategies based on identifiable molecular characteristics of the tumor. The landmark studies demonstrating the importance of mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, D. Nathan, Nam, Taek-Keun, Choe, Kevin S., Choy, Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394867/
https://www.ncbi.nlm.nih.gov/pubmed/22802745
http://dx.doi.org/10.4143/crt.2012.44.2.74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394867/
https://www.ncbi.nlm.nih.gov/pubmed/22802745
http://dx.doi.org/10.4143/crt.2012.44.2.74

Ejemplares similares